277 related articles for article (PubMed ID: 28840564)
1. Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.
Tu X; Li S; Zhao L; Xiao R; Wang X; Zhu F
Virol Sin; 2017 Aug; 32(4):280-289. PubMed ID: 28840564
[TBL] [Abstract][Full Text] [Related]
2. Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes.
Mullins CS; Linnebacher M
Cancer Immunol Immunother; 2012 Jul; 61(7):1093-100. PubMed ID: 22187063
[TBL] [Abstract][Full Text] [Related]
3. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
Ruprecht K; Gronen F; Sauter M; Best B; Rieckmann P; Mueller-Lantzsch N
J Neurovirol; 2008 Apr; 14(2):143-51. PubMed ID: 18444086
[TBL] [Abstract][Full Text] [Related]
4. Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREB.
Li S; Liu ZC; Yin SJ; Chen YT; Yu HL; Zeng J; Zhang Q; Zhu F
Neuroscience; 2013 Sep; 247():164-74. PubMed ID: 23727510
[TBL] [Abstract][Full Text] [Related]
5. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.
Ramasamy R; Mohammed F; Meier UC
Immunol Lett; 2020 Jan; 217():15-24. PubMed ID: 31689443
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.
Rycaj K; Plummer JB; Yin B; Li M; Garza J; Radvanyi L; Ramondetta LM; Lin K; Johanning GL; Tang DG; Wang-Johanning F
Clin Cancer Res; 2015 Jan; 21(2):471-83. PubMed ID: 25370465
[TBL] [Abstract][Full Text] [Related]
7. Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases.
Arru G; Mameli G; Deiana GA; Rassu AL; Piredda R; Sechi E; Caggiu E; Bo M; Nako E; Urso D; Mariotto S; Ferrari S; Zanusso G; Monaco S; Sechi G; Sechi LA
Eur J Neurol; 2018 Aug; 25(8):1076-e84. PubMed ID: 29603839
[TBL] [Abstract][Full Text] [Related]
8. HERV-W ENV Induces Innate Immune Activation and Neuronal Apoptosis via linc01930/cGAS Axis in Recent-Onset Schizophrenia.
Li X; Wu X; Li W; Yan Q; Zhou P; Xia Y; Yao W; Zhu F
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769337
[TBL] [Abstract][Full Text] [Related]
9. Elevation of Ser9 phosphorylation of GSK3β is required for HERV-W env-mediated BDNF signaling in human U251 cells.
Qin C; Li S; Yan Q; Wang X; Chen Y; Zhou P; Lu M; Zhu F
Neurosci Lett; 2016 Aug; 627():84-91. PubMed ID: 27235578
[TBL] [Abstract][Full Text] [Related]
10. Human endogenous retrovirus W family envelope protein (HERV-W env) facilitates the production of TNF-α and IL-10 by inhibiting MyD88s in glial cells.
Wang X; Wu X; Huang J; Li H; Yan Q; Zhu F
Arch Virol; 2021 Apr; 166(4):1035-1045. PubMed ID: 33438105
[TBL] [Abstract][Full Text] [Related]
11. Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.
Laufer G; Mayer J; Mueller BF; Mueller-Lantzsch N; Ruprecht K
Retrovirology; 2009 Apr; 6():37. PubMed ID: 19368703
[TBL] [Abstract][Full Text] [Related]
12. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
[TBL] [Abstract][Full Text] [Related]
13. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.
Mameli G; Astone V; Arru G; Marconi S; Lovato L; Serra C; Sotgiu S; Bonetti B; Dolei A
J Gen Virol; 2007 Jan; 88(Pt 1):264-274. PubMed ID: 17170460
[TBL] [Abstract][Full Text] [Related]
14. Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis.
Ramasamy R; Joseph B; Whittall T
Immunol Lett; 2017 Mar; 183():79-85. PubMed ID: 28189601
[TBL] [Abstract][Full Text] [Related]
15. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus.
Ponferrada VG; Mauck BS; Wooley DP
Arch Virol; 2003 Apr; 148(4):659-75. PubMed ID: 12664292
[TBL] [Abstract][Full Text] [Related]
16. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
SenGupta D; Tandon R; Vieira RG; Ndhlovu LC; Lown-Hecht R; Ormsby CE; Loh L; Jones RB; Garrison KE; Martin JN; York VA; Spotts G; Reyes-Terán G; Ostrowski MA; Hecht FM; Deeks SG; Nixon DF
J Virol; 2011 Jul; 85(14):6977-85. PubMed ID: 21525339
[TBL] [Abstract][Full Text] [Related]
17. Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients.
Perron H; Mekaoui L; Bernard C; Veas F; Stefas I; Leboyer M
Biol Psychiatry; 2008 Dec; 64(12):1019-23. PubMed ID: 18760403
[TBL] [Abstract][Full Text] [Related]
18. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells.
Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J
Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642
[TBL] [Abstract][Full Text] [Related]
19. Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis.
Simula ER; Zarbo IR; Arru G; Sechi E; Meloni R; Deiana GA; Solla P; Sechi LA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203616
[TBL] [Abstract][Full Text] [Related]
20. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
Balestrieri E; Minutolo A; Petrone V; Fanelli M; Iannetta M; Malagnino V; Zordan M; Vitale P; Charvet B; Horvat B; Bernardini S; Garaci E; di Francesco P; Sinibaldi Vallebona P; Sarmati L; Grelli S; Andreoni M; Perron H; Matteucci C
EBioMedicine; 2021 Apr; 66():103341. PubMed ID: 33867312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
